keyword
https://read.qxmd.com/read/36595522/novel-dual-lsd1-hdac6-inhibitor-for-the-treatment-of-cancer
#21
JOURNAL ARTICLE
Chandru Gajendran, Subramanyam Janardhan Tantry, Naveen Sadhu M, Zainuddin Mohammed, Purushottam Dewang, Mahanandeesha Hallur, Sreekala Nair, Krishnakumar Vaithilingam, Basavaprabhu Nagayya, Sridharan Rajagopal, Dhanalakshmi Sivanandhan
Dually targeting the epigenetic proteins lysine specific demethylase 1 (LSD1) and histone deacetylases (HDACs) that play a key role in cancer cells by modulating gene repressor complexes including CoREST will have a profound effect in inhibiting tumour growth. Here, we evaluated JBI-097 a dual LSD1/HDAC6 inhibitor, for its in vitro and in vivo activities in various tumor models. In vitro, JBI-097 showed a strong potency in inhibiting LSD1 and HDAC6 enzymatic activities with the isoform selectivity over other HDACs...
2023: PloS One
https://read.qxmd.com/read/36566195/rna-n-6-methyladenosine-modification-mediates-downregulation-of-nr4a1-to-facilitate-malignancy-of-cervical-cancer
#22
JOURNAL ARTICLE
Tao Yu, Fuxia Wu, Yan Jia, Xue Zhang, Xiaozhen Qi, Zeyuan Jin, Tongxin Hao, Jianing Zhao, Ziyu Liu, Chaokun Wang, Minmin Niu, Qin Yue, Min Li, Yankun Liu
BACKGROUND: N6 -methyladenosine is the most abundant eukaryotic mRNA modification and alters a wide range of cellular processes in cancer. Therefore, defining the molecular details are critical for understanding the regulatory mechanism of m6 A modification. RESULTS: We found that METTL3, a core m6 A methyltransferase component, is upregulated and functions as an oncogene in cervical cancer. Mechanistically, METTL3 induces the degradation of m6 A-modified transcripts of NR4A1 though YTHDF2-DDX6 pathway...
December 25, 2022: Cell & Bioscience
https://read.qxmd.com/read/36555772/-phf21a-related-disorder-description-of-a-new-case
#23
Ambra Butera, Antonio Gennaro Nicotera, Gabriella Di Rosa, Sebastiano Antonino Musumeci, Girolamo Aurelio Vitello, Antonino Musumeci, Mirella Vinci, Angelo Gloria, Concetta Federico, Salvatore Saccone, Francesco Calì
PHF21A ( PHD finger protein 21A ) gene, located in the short arm of chromosome 11, encodes for BHC80, a component of the Lysine Specific Demethylase 1, Corepressor of REST (LSD1-CoREST) complex. BHC80 is mainly expressed in the human fetal brain and skeletal muscle and acts as a modulator of several neuronal genes during embryogenesis. Data from literature relates PHF21A variants with Potocki-Shaffer Syndrome (PSS), a contiguous gene deletion disorder caused by the haploinsufficiency of PHF21A , ALX4 , and EXT2 genes...
December 17, 2022: International Journal of Molecular Sciences
https://read.qxmd.com/read/36344845/switching-under-selection-how-corest-controls-endocrine-therapy-resistance-in-er-breast-cancer
#24
JOURNAL ARTICLE
Brent Y Chick, Diana C Hargreaves
No abstract text is available yet for this article.
November 7, 2022: Nature Structural & Molecular Biology
https://read.qxmd.com/read/36344844/endocrine-resistance-and-breast-cancer-plasticity-are-controlled-by-corest
#25
JOURNAL ARTICLE
Liliana Garcia-Martinez, Andrew M Adams, Ho Lam Chan, Yuichiro Nakata, Natalia Weich, Stephanie Stransky, Zhao Zhang, Mohamed Alshalalfa, Leonor Sarria, Brandon A Mahal, Susan B Kesmodel, Toni Celià-Terrassa, Zhijie Liu, Saverio Minucci, Daniel Bilbao, Simone Sidoli, Ramiro E Verdun, Lluis Morey
Resistance to cancer treatment remains a major clinical hurdle. Here, we demonstrate that the CoREST complex is a key determinant of endocrine resistance and ER+  breast cancer plasticity. In endocrine-sensitive cells, CoREST is recruited to regulatory regions co-bound to ERα and FOXA1 to regulate the estrogen pathway. In contrast, during temporal reprogramming towards a resistant state, CoREST is recruited to AP-1 sites. In reprogrammed cells, CoREST favors chromatin opening, cJUN binding to chromatin, and gene activation by controlling SWI/SNF recruitment independently of the demethylase activity of the CoREST subunit LSD1...
November 7, 2022: Nature Structural & Molecular Biology
https://read.qxmd.com/read/36308380/anti-proliferative-effect-of-potential-lsd1-corest-inhibitors-based-on-molecular-dynamics-model-for-treatment-of-sh-sy5y-neuroblastoma-cancer-cell-line
#26
JOURNAL ARTICLE
Hiba Zalloum, Waleed Zalloum, Tareq Hameduh, Husam ALSalamat, Malek Zihlif
BACKGROUND: Lysine-specific demethylase is a demethylase enzyme that can remove methyl groups from histones H3K4me1/2 and H3K9me1/2. It is expressed in many cancers, where it impedes differentiation and contributes to cancer cell proliferation, cell metastasis and invasiveness, and is associated with inferior prognosis. LSD1 is associated with its corepressor protein CoREST, and utilizes tetrahydrofolate as a cofactor to accept CH2 from the demethylation process. The fact that the cofactor is best bound to the active site inspired us to explore its interactions to LSD1/CoREST enzyme complex utilizing molecular dynamics simulation, which aids designing novel and potent inhibitors...
October 1, 2022: Asian Pacific Journal of Cancer Prevention: APJCP
https://read.qxmd.com/read/36307542/combinatorial-gene-targeting-in-primary-human-hematopoietic-stem-and-progenitor-cells
#27
JOURNAL ARTICLE
Alexandra Bäckström, David Yudovich, Kristijonas Žemaitis, Ludvig Nilsén Falck, Agatheeswaran Subramaniam, Jonas Larsson
The CRISPR/Cas9 system offers enormous versatility for functional genomics but many applications have proven to be challenging in primary human cells compared to cell lines or mouse cells. Here, to establish a paradigm for multiplexed gene editing in primary human cord blood-derived hematopoietic stem and progenitor cells (HSPCs), we used co-delivery of lentiviral sgRNA vectors expressing either Enhanced Green Fluorescent Protein (EGFP) or Kusabira Orange (KuO), together with Cas9 mRNA, to simultaneously edit two genetic loci...
October 28, 2022: Scientific Reports
https://read.qxmd.com/read/35999597/a-developmental-role-for-the-chromatin-regulating-corest-complex-in-the-cnidarian-nematostella-vectensis
#28
JOURNAL ARTICLE
James M Gahan, Lucas Leclère, Maria Hernandez-Valladares, Fabian Rentzsch
BACKGROUND: Chromatin-modifying proteins are key players in the regulation of development and cell differentiation in animals. Most chromatin modifiers, however, predate the evolution of animal multicellularity, and how they gained new functions and became integrated into the regulatory networks underlying development is unclear. One way this may occur is the evolution of new scaffolding proteins that integrate multiple chromatin regulators into larger complexes that facilitate coordinated deposition or removal of different chromatin modifications...
August 23, 2022: BMC Biology
https://read.qxmd.com/read/35994477/a-toolbox-for-class-i-hdacs-reveals-isoform-specific-roles-in-gene-regulation-and-protein-acetylation
#29
JOURNAL ARTICLE
Lena Hess, Verena Moos, Arnel A Lauber, Wolfgang Reiter, Michael Schuster, Natascha Hartl, Daniel Lackner, Thorina Boenke, Anna Koren, Paloma M Guzzardo, Brigitte Gundacker, Anna Riegler, Petra Vician, Claudia Miccolo, Susanna Leiter, Mahesh B Chandrasekharan, Terezia Vcelkova, Andrea Tanzer, Jun Qi Jun, James Bradner, Gerald Brosch, Markus Hartl, Christoph Bock, Tilmann Bürckstümmer, Stefan Kubicek, Susanna Chiocca, Srividya Bhaskara, Christian Seiser
The class I histone deacetylases are essential regulators of cell fate decisions in health and disease. While pan- and class-specific HDAC inhibitors are available, these drugs do not allow a comprehensive understanding of individual HDAC function, or the therapeutic potential of isoform-specific targeting. To systematically compare the impact of individual catalytic functions of HDAC1, HDAC2 and HDAC3, we generated human HAP1 cell lines expressing catalytically inactive HDAC enzymes. Using this genetic toolbox we compare the effect of individual HDAC inhibition with the effects of class I specific inhibitors on cell viability, protein acetylation and gene expression...
August 22, 2022: PLoS Genetics
https://read.qxmd.com/read/35926274/mtor-and-hdac2-are-simultaneously-activated-during-electrically-induced-kindling-of-seizures
#30
JOURNAL ARTICLE
Natalia Chmielewska, Adriana Wawer, Bartosz Osuch, Piotr Maciejak, Janusz Szyndler
Although neurotrophic pathways and epigenetic processes are believed to be significant contributors to epileptogenesis and epilepsy, therapies using modulators of these targets are still lacking. BDNF-TrkB-mTOR signalling and the REST/NRSF-coREST-HDAC2 system are critical pathways responsible for neurotrophic and epigenetic processes, respectively. In our study, we assessed whether these two pathways are activated in a kindling model of seizures. We assessed the protein and mRNA levels of BDNF, TrkB, mTOR, REST/NRSF, coREST and HDAC2 in the brain...
July 29, 2022: Epilepsy Research
https://read.qxmd.com/read/35803024/distinct-biochemical-properties-of-the-class-i-histone-deacetylase-complexes
#31
REVIEW
Kwangwoon Lee, Samuel D Whedon, Zhipeng A Wang, Philip A Cole
Classical histone deacetylases (HDACs) are enzymes that can hydrolytically cleave acetyl-Lys in histones and other proteins and serve as established drug targets in some forms of cancer. Class I HDACs 1-3 typically exist in a range of multiprotein complexes inside cells and show distinct biological functions in modulating gene expression. In recent years, it has become possible to purify and analyze the structure and enzymatic properties of several of these HDAC complexes, including CoREST, MiDAC, NuRD, Sin3, SMRT, MIER, and RERE...
October 2022: Current Opinion in Chemical Biology
https://read.qxmd.com/read/35797416/recruitment-of-the-corest-transcription-repressor-complexes-by-nerve-growth-factor-ib-like-receptor-nurr1-nr4a2-mediates-silencing-of-hiv-in-microglial-cells
#32
JOURNAL ARTICLE
Fengchun Ye, David Alvarez-Carbonell, Kien Nguyen, Konstantin Leskov, Yoelvis Garcia-Mesa, Sheetal Sreeram, Saba Valadkhan, Jonathan Karn
Human immune deficiency virus (HIV) infection in the brain leads to chronic neuroinflammation due to the production of pro-inflammatory cytokines, which in turn promotes HIV transcription in infected microglial cells. However, powerful counteracting silencing mechanisms in microglial cells result in the rapid shutdown of HIV expression after viral reactivation to limit neuronal damage. Here we investigated whether the Nerve Growth Factor IB-like nuclear receptor Nurr1 (NR4A2), which is a repressor of inflammation in the brain, acts directly to restrict HIV expression...
July 7, 2022: PLoS Pathogens
https://read.qxmd.com/read/35747969/recent-progress-in-histone-deacetylase-hdac-1-inhibitors-as-anticancer-agent
#33
JOURNAL ARTICLE
Preeti Patel, Simranpreet K Wahan, S Vishakha, Balak Das Kurmi, Ghanshyam Das Gupta, Harish Rajak, Vivek Asati
Histone deacetylases (HDACs) are essential for maintaining homeostasis by catalyzing histone deacetylation. Aberrant expression of HDACs is associated with various human diseases. Although HDAC inhibitors are used as effective chemotherapeutic agents in clinical practice, their applications remain limited due to associated side effects induced by weak isoform selectivity. HDAC1 displays unique structure and cellular localization as well as diverse substrates and exhibits a wider range of biological functions than other isoforms...
June 24, 2022: Current Cancer Drug Targets
https://read.qxmd.com/read/35687133/tbx2-acts-as-a-potent-transcriptional-silencer-of-tumour-suppressor-genes-through-interaction-with-the-corest-complex-to-sustain-the-proliferation-of-breast-cancers
#34
JOURNAL ARTICLE
Alexander J McIntyre, Charlotte Z Angel, James S Smith, Amy Templeman, Katherine Beattie, Shannon Beattie, Alice Ormrod, Eadaoin Devlin, Charles McGreevy, Chloe Bothwell, Sharon L Eddie, Niamh E Buckley, Rich Williams, Paul B Mullan
Chromosome 17q23 amplification occurs in 20% of primary breast tumours and is associated with poor outcome. The TBX2 gene is located on 17q23 and is often over-expressed in this breast tumour subset. TBX2 is an anti-senescence gene, promoting cell growth and survival through repression of Tumour Suppressor Genes (TSGs), such as NDRG1 and CST6. Previously we found that TBX2 cooperates with the PRC2 complex to repress several TSGs, and that PRC2 inhibition restored NDRG1 expression to impede cellular proliferation...
June 24, 2022: Nucleic Acids Research
https://read.qxmd.com/read/35593350/role-of-lysine-specific-demethylase-1-and-its-small-molecule-inhibitors-in-glioblastoma-multiforme-therapy
#35
REVIEW
Rangan Mitra, Senthil Raja Ayyannan
Glioblastoma multiforme (GBM) is among the most critical and aggressive carcinomas of CNS, characterised by poor prognosis, low survival rate and difficult clinical correlations. Current treatment opportunities have proved to be insufficient due to high chemoresistance and relapse of the disease with enhanced malignancy. Molecular diagnostics and epigenetic profiling of GBM have discovered several signaling pathways and cellular mediators, which play key roles in triggering GBM phenotypic manifestations via somatic and genetic aberrations and recruitment of GBM stem-like cells (GSCs)...
2022: Anti-cancer Agents in Medicinal Chemistry
https://read.qxmd.com/read/35379950/disease-associated-kbtbd4-mutations-in-medulloblastoma-elicit-neomorphic-ubiquitylation-activity-to-promote-corest-degradation
#36
JOURNAL ARTICLE
Zhuoyao Chen, Rafael M Ioris, Stacey Richardson, Ava N Van Ess, Iolanda Vendrell, Benedikt M Kessler, Francesca M Buffa, Luca Busino, Steven C Clifford, Alex N Bullock, Vincenzo D'Angiolella
Medulloblastoma is the most common malignant brain tumour in children. Genomic studies have identified distinct disease subgroups: wnt/wingless (WNT), sonic hedgehog (SHH), and non-WNT/non-SHH, comprising group 3 and group 4. Alterations in WNT and SHH signalling form the pathogenetic basis for their subgroups, whereas those for non-WNT/non-SHH tumours remain largely elusive. Recent analyses have revealed recurrent in-frame insertions in the E3 ubiquitin ligase adaptor Kelch Repeat and BTB Domain Containing 4 (KBTBD4) in cases of group 3/4 medulloblastoma...
April 4, 2022: Cell Death and Differentiation
https://read.qxmd.com/read/35317680/heterocycle-containing-tranylcypromine-derivatives-endowed-with-high-anti-lsd1-activity
#37
JOURNAL ARTICLE
Rossella Fioravanti, Veronica Rodriguez, Jonatan Caroli, Ugo Chianese, Rosaria Benedetti, Elisabetta Di Bello, Beatrice Noce, Clemens Zwergel, Davide Corinti, Dolores Viña, Lucia Altucci, Andrea Mattevi, Sergio Valente, Antonello Mai
As regioisomers/bioisosteres of 1a , a 4-phenylbenzamide tranylcypromine (TCP) derivative previously disclosed by us, we report here the synthesis and biological evaluation of some (hetero)arylbenzoylamino TCP derivatives 1b - 6 , in which the 4-phenyl moiety of 1a was shifted at the benzamide C3 position or replaced by 2- or 3-furyl, 2- or 3-thienyl, or 4-pyridyl group, all at the benzamide C4 or C3 position. In anti-LSD1-CoREST assay, all the meta derivatives were more effective than the para analogues, with the meta thienyl analogs 4b and 5b being the most potent (IC50 values = 0...
December 2022: Journal of Enzyme Inhibition and Medicinal Chemistry
https://read.qxmd.com/read/35317226/role-of-the-nuclear-receptor-subfamily-4a-in-mast-cells-in-the-development-of-irritable-bowel-syndrome
#38
REVIEW
Ruidi Li, Shuhui Chen, Xinpei Gu, Shuhong An, Zhaojin Wang
The activation of mast cells (MCs) and mediator release are closely related to the pathophysiology of irritable bowel syndrome (IBS). However, the exact underlying mechanisms are still not completely understood. The nuclear receptor subfamily 4a (Nr4a) is a family of orphan nuclear receptors implicated in regulating MC activation, degranulation, cytokine/chemokine synthesis and release. Acute and chronic stress trigger hypothalamic-pituitaryadrenal axis (HPA) activation to induce the release of corticotropin-releasing hormone (CRH), resulting in MC activation and induction of the Nr4a family...
2022: Computational and Structural Biotechnology Journal
https://read.qxmd.com/read/35069829/silencing-corest-inhibits-the-viability-and-migration-of-fibroblast-like-synoviocytes-in-tnf-%C3%AE-induced-rheumatoid-arthritis
#39
JOURNAL ARTICLE
Ziliang Yu, Feihu Chen, Hao Liu, Jianbo Fan, Xiaomin Ding, Xinhui Zhu, Shengyu Cui, Hong Yi, Xiaogang Zhou, Yalong Hu, Wei Liu
Fibroblast-like synoviocytes (FLSs) have functions in the pathogenesis of rheumatoid arthritis (RA) through the onset of synovitis, the growth of pannus and the destruction of cartilage and bone. The significant increase in the proliferation, migration and invasion of FLSs induces the onset and advancement of RA. To date, the exact function of corepressor element-1 silencing transcription factor (CoREST) in RA remains unclear, but its expression has been determined in RA synovial tissues. In this study, the effects of CoREST were investigated in a TNF-α-induced FLS activation model...
February 2022: Experimental and Therapeutic Medicine
https://read.qxmd.com/read/34935912/proteomic-analysis-identifies-zmym2-as-endogenous-binding-partner-of-tbx18-protein-in-293-and-a549-cells
#40
JOURNAL ARTICLE
Timo H-W Lüdtke, Marc-Jens Kleppa, Reginaldo Rivera-Reyes, Fairouz Qasrawi, Dervla M Connaughton, Shirlee Shril, Friedhelm Hildebrandt, Andreas Kispert
The TBX18 transcription factor regulates patterning and differentiation programs in the primordia of many organs yet the molecular complexes in which TBX18 resides to exert its crucial transcriptional function in these embryonic contexts have remained elusive. Here, we used 293 and A549 cells as an accessible cell source to search for endogenous protein interaction partners of TBX18 by an unbiased proteomic approach. We tagged endogenous TBX18 by CRISPR/Cas9 targeted genome editing with a triple FLAG peptide, and identified by anti-FLAG affinity purification and subsequent LC-MS analysis the ZMYM2 protein to be statistically enriched together with TBX18 in both 293 and A549 nuclear extracts...
January 14, 2022: Biochemical Journal
keyword
keyword
58382
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.